HealthDay

Threats from these products include choking, strangulation, injury to the mouth, infection

Patients at risk include those with hypertension or certain genetic disorders and the elderly

Associations seen for both Alzheimer’s disease-related dementia and cerebrovascular etiologies

Reduced odds of perioperative complications seen for overlapping surgery versus nonoverlapping surgery

Upper gastrointestinal bleeding hospitalization risk lower for anticoagulant tx with PPI cotherapy

Prolongs survival among patients with recurrent, metastatic head and neck squamous cell carcinoma

Forty percent decrease seen in harmful errors; decrease also in nonpreventable adverse events

Prevalence ratio for any cardiovascular disease was 2.18 for those working with pesticides

Estimated risk from age 25 years onward is 24.9 percent, with geographic variation in risk

Two-year progression-free survival rate 81 percent with sorafenib vs. 36 percent with placebo

Updates include use of SGLT-2 inhibitors and GLP-1 receptor agonists for T2DM, CVD; endorsed by ACC

OCT probe integrated into standard brain biopsy needle IDs vessels with high sensitivity, specificity

Significantly faster increase in use of telemental health services seen in counties with no psychiatrists

When treated for atrial fibrillation, quality of anticoagulant use lower in blacks, Hispanics

Misuse accounted for 17.2 percent of overall use; highest misuse reported for those aged 18 to 25 years

Female sterilization is most commonly used method, followed by oral contraceptive pill

As of last Saturday’s enrollment deadline, 8.5 million people in 39 states had enrolled

So-called legacy prescribing can contribute to overmedication and adverse drug events

Findings observed in early-stage breast cancer survivors followed for up to six years after treatment